Julian Burks

625 total citations
16 papers, 493 citations indexed

About

Julian Burks is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Julian Burks has authored 16 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Julian Burks's work include Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and interferon and immune responses (3 papers). Julian Burks is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and interferon and immune responses (3 papers). Julian Burks collaborates with scholars based in United States, Spain and Austria. Julian Burks's co-authors include Shyamal D. Desai, Ryan Reed, Yehenew M. Agazie, Jill P. Smith, Karina Ramírez, N. Mazurek, Yu Sun, James C. Byrd, Margarete Hafley and Robert S. Bresalier and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Julian Burks

14 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julian Burks United States	11	289	262	186	60	44	16	493
Polina Weitzenfeld Israel	8	240 0.8×	288 1.1×	306 1.6×	79 1.3×	26 0.6×	9	573
Hanako Daino Japan	10	326 1.1×	174 0.7×	153 0.8×	52 0.9×	24 0.5×	11	486
Caren Jayasinghe Germany	10	204 0.7×	182 0.7×	286 1.5×	138 2.3×	20 0.5×	16	510
Frédéric Princen Belgium	12	524 1.8×	200 0.8×	174 0.9×	76 1.3×	68 1.5×	15	655
Lizhi Zhang United States	10	309 1.1×	84 0.3×	163 0.9×	104 1.7×	41 0.9×	18	474
Theresa L. Whiteside United States	10	207 0.7×	417 1.6×	277 1.5×	65 1.1×	23 0.5×	13	650
Jesper Zeuthen Denmark	8	233 0.8×	194 0.7×	251 1.3×	52 0.9×	24 0.5×	9	475
Kristen F. Meckel United States	4	196 0.7×	522 2.0×	327 1.8×	37 0.6×	14 0.3×	5	744
Jae K. Lee United States	7	165 0.6×	107 0.4×	119 0.6×	98 1.6×	38 0.9×	8	391
David S.L. Kim United States	7	238 0.8×	144 0.5×	118 0.6×	101 1.7×	21 0.5×	8	406

Countries citing papers authored by Julian Burks

Since Specialization

Citations

This map shows the geographic impact of Julian Burks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Burks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Burks more than expected).

Fields of papers citing papers by Julian Burks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julian Burks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Burks. The network helps show where Julian Burks may publish in the future.

Co-authorship network of co-authors of Julian Burks

This figure shows the co-authorship network connecting the top 25 collaborators of Julian Burks. A scholar is included among the top collaborators of Julian Burks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Burks. Julian Burks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Burks, Julian, Shweta Tiwary, David M. Stevens, et al.. (2025). PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors. Journal for ImmunoTherapy of Cancer. 13(3). e009539–e009539.

Burks, Julian, Purevdorj B. Olkhanud, & Jay A. Berzofsky. (2021). The role of NKT cells in gastrointestinal cancers. OncoImmunology. 11(1). 2009666–2009666. 9 indexed citations

Burks, Julian, et al.. (2019). ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression. Cancer Immunology Immunotherapy. 68(12). 2029–2039. 25 indexed citations

Burks, Julian, et al.. (2019). Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment. Cancer Immunology Immunotherapy. 68(10). 1635–1648. 16 indexed citations

Smith, Jill P., et al.. (2019). Gastrin vaccine and immune checkpoint antibody therapy for pancreatic cancer.. Journal of Clinical Oncology. 37(4_suppl). 259–259.

Nadella, Sandeep, Julian Burks, Juan Wang, et al.. (2019). Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis. Pancreas. 48(7). 894–903. 8 indexed citations

Burks, Julian, Sandeep Nadella, Abdullah Mahmud, et al.. (2018). Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer. Cellular and Molecular Gastroenterology and Hepatology. 6(1). 17–32. 18 indexed citations

Moreno‐Viedma, Verónica, Matteo Tardelli, Maximilian Zeyda, et al.. (2018). Osteopontin-deficient progenitor cells display enhanced differentiation to adipocytes. Obesity Research & Clinical Practice. 12(3). 277–285. 13 indexed citations

Nadella, Sandeep, Juan Wang, Bhaskar Kallakury, et al.. (2018). 389 - Endogenous Gastrin Collaborates with Mutant Kras in Pancreatic Carcinogenesis. Gastroenterology. 154(6). S–94. 1 indexed citations

10.

Nadella, Sandeep, et al.. (2018). Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor. American Journal of Physiology-Gastrointestinal and Liver Physiology. 315(5). G699–G712. 31 indexed citations

11.

Burks, Julian, Ryan Reed, & Shyamal D. Desai. (2015). Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective. Oncotarget. 6(9). 7221–7231. 65 indexed citations

12.

Burks, Julian, Ryan Reed, & Shyamal D. Desai. (2013). ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene. 33(6). 794–803. 75 indexed citations

13.

Mazurek, N., James C. Byrd, Yu Sun, et al.. (2011). Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death and Differentiation. 19(3). 523–533. 77 indexed citations

14.

Desai, Shyamal D., Ryan Reed, Julian Burks, et al.. (2011). ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Experimental Biology and Medicine. 237(1). 38–49. 85 indexed citations

15.

Burks, Julian & Yehenew M. Agazie. (2006). Modulation of α-catenin Tyr phosphorylation by SHP2 positively effects cell transformation induced by the constitutively active FGFR3. Oncogene. 25(54). 7166–7179. 32 indexed citations

16.

Wang, Jian, Timothy D. Wiltshire, Yutian Wang, et al.. (2004). ATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven. Journal of Biological Chemistry. 279(38). 39584–39592. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact